Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
2017 · The Lancet Neurology · 900 citations
https://doi.org/10.1016/s1474-4422(17)30115-1
K
Koji Abe
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
101
Citations
5
h-index
4
i10-index
Koji Abe is an academic researcher from Municipal Hirakata City Hospital. The author has contributed to research in topics: Parkinson's Disease Mechanisms and Treatments & Coronary Interventions and Diagnostics & Acute Myocardial Infarction Research. The author has an h-index of 5, co-authored 6 publications.
Papers by this author
worksTherapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis
2020 · Scientific Reports · 43 citations
https://doi.org/10.1038/s41598-020-74216-4
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis
2022 · JAMA Neurology · 78 citations
https://doi.org/10.1001/jamaneurol.2022.0901
Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort
2015 · Neurobiology of Aging · 67 citations
https://doi.org/10.1016/j.neurobiolaging.2015.11.030
A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with amyotrophic lateral sclerosis
2020 · Communications Biology · 66 citations
https://doi.org/10.1038/s42003-020-01251-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat